# LISS-0559 Phase 3 Refactor review

- Issue/WP: LISS-0559 / WP-0161
- Path/phase: Feature Path / Phase 3 Refactor
- Review isolation: same_context, per `docs/collaboration/runtime-routing.toml`
- Approval received: `LISS-0559 Phase 3 Refactor 承認`, 2026-09-16
- Implementation permission: completed for the approved Phase 2 scope; no
  additional behavior change authorized by this review

## Review result

The implementation is readable and no additional production refactor is
necessary. `AssayRecord` owns the typed immutable record fields,
`FrozenAssaySnapshot` owns copied source metadata and normalized records, and
curation owns profile validation and quarantine decisions. The DTO does not
perform chemistry normalization, model fitting, persistence, or provider work.

## Boundary review

- Censored relations remain `=`, `<`, or `>` without silent conversion.
- Identity and replicate collisions quarantine while retaining both records.
- Raw input mappings are copied and are not mutated.
- The reviewed D01 tests remain unchanged.
- No external data, database, QPU, or deployment boundary was added.

## Verification

- Complete D01 suite: **7 passed**.
- `py_compile`: passed.
- `git diff --check`: passed.
- test lifecycle, document lifecycle, and coverage-ledger checks: passed.

## Next gate

Request `LISS-0559 Phase 3 最終レビュー 承認`.
